Logo image of MELE.BR

MELEXIS NV (MELE.BR) Stock Fundamental Analysis

EBR:MELE - Euronext Brussels - BE0165385973 - Common Stock - Currency: EUR

57.25  -0.8 (-1.38%)

Fundamental Rating

6

Overall MELE gets a fundamental rating of 6 out of 10. We evaluated MELE against 53 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the health and profitability get an excellent rating, making MELE a very profitable company, without any liquidiy or solvency issues. MELE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

MELE had positive earnings in the past year.
MELE had a positive operating cash flow in the past year.
Each year in the past 5 years MELE has been profitable.
In the past 5 years MELE always reported a positive cash flow from operatings.
MELE.BR Yearly Net Income VS EBIT VS OCF VS FCFMELE.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of 19.17%, MELE belongs to the top of the industry, outperforming 90.57% of the companies in the same industry.
MELE has a Return On Equity of 30.21%. This is in the better half of the industry: MELE outperforms 79.25% of its industry peers.
Looking at the Return On Invested Capital, with a value of 23.13%, MELE belongs to the top of the industry, outperforming 88.68% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for MELE is significantly above the industry average of 15.09%.
The last Return On Invested Capital (23.13%) for MELE is well below the 3 year average (31.03%), which needs to be investigated, but indicates that MELE had better years and this may not be a problem.
Industry RankSector Rank
ROA 19.17%
ROE 30.21%
ROIC 23.13%
ROA(3y)25.78%
ROA(5y)24.35%
ROE(3y)36.37%
ROE(5y)32.97%
ROIC(3y)31.03%
ROIC(5y)28.48%
MELE.BR Yearly ROA, ROE, ROICMELE.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

Looking at the Profit Margin, with a value of 18.38%, MELE is in the better half of the industry, outperforming 64.15% of the companies in the same industry.
MELE's Profit Margin has improved in the last couple of years.
MELE has a Operating Margin of 23.57%. This is in the better half of the industry: MELE outperforms 66.04% of its industry peers.
MELE's Operating Margin has improved in the last couple of years.
MELE has a Gross Margin (43.03%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of MELE has grown nicely.
Industry RankSector Rank
OM 23.57%
PM (TTM) 18.38%
GM 43.03%
OM growth 3Y0.51%
OM growth 5Y8.98%
PM growth 3Y-3.36%
PM growth 5Y8.23%
GM growth 3Y0.09%
GM growth 5Y1.54%
MELE.BR Yearly Profit, Operating, Gross MarginsMELE.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MELE is creating value.
MELE has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for MELE has been increased compared to 5 years ago.
Compared to 1 year ago, MELE has a worse debt to assets ratio.
MELE.BR Yearly Shares OutstandingMELE.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MELE.BR Yearly Total Debt VS Total AssetsMELE.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

MELE has an Altman-Z score of 7.55. This indicates that MELE is financially healthy and has little risk of bankruptcy at the moment.
MELE's Altman-Z score of 7.55 is fine compared to the rest of the industry. MELE outperforms 73.58% of its industry peers.
The Debt to FCF ratio of MELE is 1.78, which is an excellent value as it means it would take MELE, only 1.78 years of fcf income to pay off all of its debts.
MELE has a Debt to FCF ratio of 1.78. This is in the better half of the industry: MELE outperforms 67.92% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that MELE is not too dependend on debt financing.
MELE has a Debt to Equity ratio of 0.38. This is in the lower half of the industry: MELE underperforms 66.04% of its industry peers.
Although MELE does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 1.78
Altman-Z 7.55
ROIC/WACC2.15
WACC10.75%
MELE.BR Yearly LT Debt VS Equity VS FCFMELE.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

MELE has a Current Ratio of 4.54. This indicates that MELE is financially healthy and has no problem in meeting its short term obligations.
MELE has a better Current ratio (4.54) than 86.79% of its industry peers.
MELE has a Quick Ratio of 2.01. This indicates that MELE is financially healthy and has no problem in meeting its short term obligations.
MELE has a Quick ratio of 2.01. This is in the better half of the industry: MELE outperforms 75.47% of its industry peers.
Industry RankSector Rank
Current Ratio 4.54
Quick Ratio 2.01
MELE.BR Yearly Current Assets VS Current LiabilitesMELE.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

MELE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.34%.
Measured over the past years, MELE shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.04% on average per year.
Looking at the last year, MELE shows a decrease in Revenue. The Revenue has decreased by -3.27% in the last year.
MELE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.89% yearly.
EPS 1Y (TTM)-18.34%
EPS 3Y9.29%
EPS 5Y23.04%
EPS Q2Q%-63.41%
Revenue 1Y (TTM)-3.27%
Revenue growth 3Y13.16%
Revenue growth 5Y13.89%
Sales Q2Q%-21.19%

3.2 Future

The Earnings Per Share is expected to grow by 9.86% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.48% on average over the next years.
EPS Next Y-25.62%
EPS Next 2Y-0.54%
EPS Next 3Y4.79%
EPS Next 5Y9.86%
Revenue Next Year-11.57%
Revenue Next 2Y0.06%
Revenue Next 3Y3.24%
Revenue Next 5Y5.48%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MELE.BR Yearly Revenue VS EstimatesMELE.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
MELE.BR Yearly EPS VS EstimatesMELE.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.53, the valuation of MELE can be described as correct.
Based on the Price/Earnings ratio, MELE is valued cheaply inside the industry as 81.13% of the companies are valued more expensively.
MELE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.82.
With a Price/Forward Earnings ratio of 18.20, MELE is valued on the expensive side.
MELE's Price/Forward Earnings is on the same level as the industry average.
MELE's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.76.
Industry RankSector Rank
PE 13.53
Fwd PE 18.2
MELE.BR Price Earnings VS Forward Price EarningsMELE.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

MELE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MELE is cheaper than 60.38% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MELE indicates a rather cheap valuation: MELE is cheaper than 88.68% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.49
EV/EBITDA 9.47
MELE.BR Per share dataMELE.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

MELE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.59
EPS Next 2Y-0.54%
EPS Next 3Y4.79%

6

5. Dividend

5.1 Amount

MELE has a Yearly Dividend Yield of 4.46%, which is a nice return.
MELE's Dividend Yield is rather good when compared to the industry average which is at 1.37. MELE pays more dividend than 100.00% of the companies in the same industry.
MELE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 4.46%

5.2 History

The dividend of MELE is nicely growing with an annual growth rate of 10.98%!
Dividend Growth(5Y)10.98%
Div Incr Years3
Div Non Decr Years6
MELE.BR Yearly Dividends per shareMELE.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

87.19% of the earnings are spent on dividend by MELE. This is not a sustainable payout ratio.
MELE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP87.19%
EPS Next 2Y-0.54%
EPS Next 3Y4.79%
MELE.BR Yearly Income VS Free CF VS DividendMELE.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M
MELE.BR Dividend Payout.MELE.BR Dividend Payout, showing the Payout Ratio.MELE.BR Dividend Payout.PayoutRetained Earnings

MELEXIS NV

EBR:MELE (5/23/2025, 7:00:00 PM)

57.25

-0.8 (-1.38%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-30 2025-07-30
Inst Owners16.78%
Inst Owner ChangeN/A
Ins Owners25.01%
Ins Owner ChangeN/A
Market Cap2.31B
Analysts76.67
Price Target62.64 (9.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.46%
Yearly Dividend3.7
Dividend Growth(5Y)10.98%
DP87.19%
Div Incr Years3
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.09%
Min EPS beat(2)-38.45%
Max EPS beat(2)-1.73%
EPS beat(4)1
Avg EPS beat(4)-9.23%
Min EPS beat(4)-38.45%
Max EPS beat(4)9.1%
EPS beat(8)4
Avg EPS beat(8)-4.63%
EPS beat(12)7
Avg EPS beat(12)-0.24%
EPS beat(16)10
Avg EPS beat(16)2.37%
Revenue beat(2)0
Avg Revenue beat(2)-4.03%
Min Revenue beat(2)-5.22%
Max Revenue beat(2)-2.83%
Revenue beat(4)0
Avg Revenue beat(4)-2.93%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.68%
Revenue beat(8)1
Avg Revenue beat(8)-2.02%
Revenue beat(12)4
Avg Revenue beat(12)-1.17%
Revenue beat(16)6
Avg Revenue beat(16)5.08%
PT rev (1m)-5.92%
PT rev (3m)-17.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-18.35%
EPS NY rev (1m)0%
EPS NY rev (3m)-23.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.13%
Revenue NY rev (1m)-2.25%
Revenue NY rev (3m)-9.04%
Valuation
Industry RankSector Rank
PE 13.53
Fwd PE 18.2
P/S 2.48
P/FCF 18.49
P/OCF 12.98
P/B 4.08
P/tB 4.08
EV/EBITDA 9.47
EPS(TTM)4.23
EY7.39%
EPS(NY)3.15
Fwd EY5.5%
FCF(TTM)3.1
FCFY5.41%
OCF(TTM)4.41
OCFY7.7%
SpS23.09
BVpS14.05
TBVpS14.02
PEG (NY)N/A
PEG (5Y)0.59
Profitability
Industry RankSector Rank
ROA 19.17%
ROE 30.21%
ROCE 27.83%
ROIC 23.13%
ROICexc 24.13%
ROICexgc 24.17%
OM 23.57%
PM (TTM) 18.38%
GM 43.03%
FCFM 13.41%
ROA(3y)25.78%
ROA(5y)24.35%
ROE(3y)36.37%
ROE(5y)32.97%
ROIC(3y)31.03%
ROIC(5y)28.48%
ROICexc(3y)38.83%
ROICexc(5y)36.08%
ROICexgc(3y)39.06%
ROICexgc(5y)36.42%
ROCE(3y)37.33%
ROCE(5y)34.27%
ROICexcg growth 3Y-14.81%
ROICexcg growth 5Y1.87%
ROICexc growth 3Y-14.47%
ROICexc growth 5Y2.21%
OM growth 3Y0.51%
OM growth 5Y8.98%
PM growth 3Y-3.36%
PM growth 5Y8.23%
GM growth 3Y0.09%
GM growth 5Y1.54%
F-Score5
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 1.78
Debt/EBITDA 0.8
Cap/Depr 111.24%
Cap/Sales 5.69%
Interest Coverage 20.46
Cash Conversion 66.58%
Profit Quality 72.96%
Current Ratio 4.54
Quick Ratio 2.01
Altman-Z 7.55
F-Score5
WACC10.75%
ROIC/WACC2.15
Cap/Depr(3y)136.47%
Cap/Depr(5y)110.04%
Cap/Sales(3y)6.76%
Cap/Sales(5y)6.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.34%
EPS 3Y9.29%
EPS 5Y23.04%
EPS Q2Q%-63.41%
EPS Next Y-25.62%
EPS Next 2Y-0.54%
EPS Next 3Y4.79%
EPS Next 5Y9.86%
Revenue 1Y (TTM)-3.27%
Revenue growth 3Y13.16%
Revenue growth 5Y13.89%
Sales Q2Q%-21.19%
Revenue Next Year-11.57%
Revenue Next 2Y0.06%
Revenue Next 3Y3.24%
Revenue Next 5Y5.48%
EBIT growth 1Y-15.83%
EBIT growth 3Y13.74%
EBIT growth 5Y24.11%
EBIT Next Year-8.55%
EBIT Next 3Y9.84%
EBIT Next 5Y10.24%
FCF growth 1Y236.29%
FCF growth 3Y6.64%
FCF growth 5Y13.04%
OCF growth 1Y5817.76%
OCF growth 3Y7.8%
OCF growth 5Y13.55%